2022
Comparative effectiveness of group v. individual trauma-focused treatment for posttraumatic stress disorder in veterans
Spiller TR, Duek O, Buta E, Gross G, Smith NB, Harpaz-Rotem I. Comparative effectiveness of group v. individual trauma-focused treatment for posttraumatic stress disorder in veterans. Psychological Medicine 2022, 53: 4561-4568. PMID: 35959560, PMCID: PMC10388318, DOI: 10.1017/s0033291722001441.Peer-Reviewed Original ResearchConceptsGroup cognitive processing therapyCognitive processing therapyPosttraumatic stress disorderIndividual cognitive processing therapyPTSD symptom severitySymptom severityStress disorderReal-world effectivenessComparative effectiveness studiesResidential treatmentEffective treatmentComparative effectivenessVeterans AffairsEffectiveness studiesPTSD ChecklistPTSD severityGroup therapySeverityVeteransTreatmentDSM-5Group V.TherapyDisordersSmall reduction
2019
Randomized Controlled Trial of Imagery Rehearsal for Posttraumatic Nightmares in Combat Veterans.
Harb GC, Cook JM, Phelps AJ, Gehrman PR, Forbes D, Localio R, Harpaz-Rotem I, Gur RC, Ross RJ. Randomized Controlled Trial of Imagery Rehearsal for Posttraumatic Nightmares in Combat Veterans. Journal Of Clinical Sleep Medicine 2019, 15: 757-767. PMID: 31053215, PMCID: PMC6510682, DOI: 10.5664/jcsm.7770.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyPosttraumatic stress disorderNightmare Distress QuestionnaireNightmare Frequency QuestionnaireBehavioral therapySevere posttraumatic stress disorderUnited States veteransOperation Enduring Freedom/Operation Iraqi Freedom veteransImagery rehearsalOperation Iraqi Freedom veteransSubgroups of veteransIraqi Freedom veteransFrequency questionnaireControlled TrialsPrimary outcomeLikelihood ratio chi-squareStates veteransDistress QuestionnaireStress disorderChi-squareRecurrent nightmaresConfidence intervalsMilitary veteransVeteransCombat veteransExamining the nonresponse phenomenon: Factors associated with treatment response in a national sample of veterans undergoing residential PTSD treatment
Sripada RK, Blow FC, Rauch SAM, Ganoczy D, Hoff R, Harpaz-Rotem I, Bohnert KM. Examining the nonresponse phenomenon: Factors associated with treatment response in a national sample of veterans undergoing residential PTSD treatment. Journal Of Anxiety Disorders 2019, 63: 18-25. PMID: 30785007, DOI: 10.1016/j.janxdis.2019.02.001.Peer-Reviewed Original ResearchConceptsResidential PTSD treatmentPTSD treatmentPTSD symptom changeTreatment-seeking veteransContextual protective factorsPhysical health resourcesNational sampleLarge national samplePsychological stateIndividual-level factorsLife eventsMultilevel modelingSymptom changeTreatment entryPoor treatment responseProtective factorsWorse treatment responsePersonality disorderPTSDBetter treatment responseTreatment responseCurrent studyGreater pain severityVeteransTheory of resources
2012
Psychotherapy use in a privately insured population of patients diagnosed with a mental disorder
Harpaz-Rotem I, Libby D, Rosenheck RA. Psychotherapy use in a privately insured population of patients diagnosed with a mental disorder. Social Psychiatry And Psychiatric Epidemiology 2012, 47: 1837-1844. PMID: 22349151, DOI: 10.1007/s00127-012-0486-9.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnxiety DisordersComorbidityDatabases as TopicDepressive Disorder, MajorFemaleHealth Care SurveysHumansInsurance CoverageInsurance, HealthLogistic ModelsMaleMental DisordersMental Health ServicesMiddle AgedPrivate SectorPsychotherapyStress Disorders, Post-TraumaticTreatment OutcomeUnited StatesConceptsMajor depressive disorderUse of psychotherapyPosttraumatic stress disorderReceipt of psychotherapyPsychotherapy visitsDepressive disorderMild depressionBipolar disorderMental disordersStress disorderAlcohol useCorrelates of receiptCurrent Procedural Terminology codesPopulation of patientsLarge claims databaseAlternative drug therapiesProcedural Terminology codesMental health servicesMultivariate binary regressionEffectiveness of psychotherapyPatient characteristicsClaims databasePharmacological treatmentDrug therapyPsychotherapy use
2011
Residential treatment for homeless female veterans with psychiatric and substance use disorders: Effect on 1-year clinical outcomes
Harpaz-Rotem I, Rosenheck RA, Desai R. Residential treatment for homeless female veterans with psychiatric and substance use disorders: Effect on 1-year clinical outcomes. The Journal Of Rehabilitation Research And Development 2011, 48: 891. PMID: 22068368, DOI: 10.1682/jrrd.2010.10.0195.Peer-Reviewed Original ResearchMeSH KeywordsAdultDiagnosis, Dual (Psychiatry)EmploymentFemaleFollow-Up StudiesHousingHumansIll-Housed PersonsLength of StayMental DisordersMiddle AgedRecurrenceResidential TreatmentSocial SupportSubstance-Related DisordersTime FactorsTreatment OutcomeUnited StatesUnited States Department of Veterans AffairsVeteransConceptsClinical outcomesResidential treatmentHomeless female veteransPsychiatric symptomsFemale veteransSerious mental illnessSubstance use disordersUse of drugsGroup of veteransMental health outcomesNRT groupRT groupPsychiatric problemsUse disordersBetter outcomesHealth outcomesMental illnessHomeless womenVeterans AffairsAlcohol useBeneficial effectsLimited evidenceSubstance useOutcomesProgram entry
2009
Tracing the Flow of Knowledge: Geographic Variability in the Diffusion of Prazosin Use for the Treatment of Posttraumatic Stress Disorder Nationally in the Department of Veterans Affairs
Harpaz-Rotem I, Rosenheck RA. Tracing the Flow of Knowledge: Geographic Variability in the Diffusion of Prazosin Use for the Treatment of Posttraumatic Stress Disorder Nationally in the Department of Veterans Affairs. JAMA Psychiatry 2009, 66: 417-421. PMID: 19349311, DOI: 10.1001/archgenpsychiatry.2008.536.Peer-Reviewed Original ResearchConceptsPosttraumatic stress disorderHealth care systemVeterans AffairsStress disorderSound Health Care SystemCare systemUse of prazosinPercentage of patientsTreatment of patientsTreatment of nightmaresPrazosin usePatient characteristicsNational health care systemMedical CenterMAIN OUTCOMEPrazosinPassive disseminationPatientsClinical practiceNew treatmentsPassive diffusionPrazosin hydrochlorideFiscal year 2004TreatmentPreliminary evidence